AVDL - Avadel Pharmaceuticals plc (AVDL) CEO Greg Divis on Q2 2020 Results - Earnings Call Transcript
Avadel Pharmaceuticals plc (AVDL)
Q2 2020 Earnings Conference Call
August 10, 2020 08:30 ET
Company Participants
Thomas McHugh - Chief Financial Officer
Greg Divis - Chief Executive Officer
Jordan Dubow - Chief Medical Officer
Conference Call Participants
Ami Fadia - Leerink
Paul Matteis - Stifel
Francois Brisebois - Craig-Hallum Capital Group
David Amsellem - Piper Jaffray
Presentation
Operator
Greetings, and welcome to the Avadel Pharmaceuticals Second Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder,